Following the administration of approximately 8 million Pfizer COVID-19 vaccine doses in children between the ages of 5 to 11 years, local and systemic reactions were closely monitored and assessed. The incoming data was reported to VAERS and v-safe, the national passive vaccine safety surveillance system, jointly managed by the CDC and FDA. During the span of 3 November to 19 December, 4,249 reports were submitted, of which 97% were for nonserious adverse events.

For the most recent clinical data regarding the safety and efficacy of the Pfizer COVID-19 vaccine in children aged 5 to 11 years, read the full VAERS report.

COVID-19 Vaccine Safety in Children Aged 5-11 Years November 3 – December 19 2021